Key result
D-dimer testing, when measured by a sensitive assay and combined with pretest clinical probability, can safely exclude venous thromboembolism in symptomatic outpatients.
Why the study?
What are the clinical applications, merits, and pitfalls of D-dimer testing in laboratory practice for thrombosis-related conditions?
What are the clinical applications, merits, and pitfalls of D-dimer testing in laboratory practice for thrombosis-related conditions?
D-dimer is a valuable laboratory tool for excluding VTE in low-probability patients, assessing recurrence risk, and managing DIC, despite its poor positive predictive value.
Answers are grounded in this paper and cite their sources.
Supports D-dimer use for outpatient VTE exclusion in low-probability cases; leaves open assay standardization and broader validation.
BACKGROUND: d-dimer is a reliable and sensitive index of fibrin deposition and stabilization. As such, its presence in plasma should be indicative of thrombus formation. There are many conditions unrelated to thrombosis in which d-dimer concentrations are high, however, making its positive predictive value rather poor. CONTENT: Notwithstanding these limitations, d-dimer can be regarded as a most valuable laboratory tool to diagnose and manage a vast array of thrombosis-related clinical conditions, including ( a ) diagnosis of venous thromboembolism (VTE), ( b ) identification of individuals at increased risk of first thrombotic event (both arterial and venous), ( c ) identification of individuals at increased risk of recurrent VTE, ( d ) establishment of the optimal duration of secondary prophylaxis after a first episode of VTE, ( e ) pregnancy monitoring, and ( f ) diagnosis/monitoring of disseminated intravascular coagulation (DIC). This article is aimed at reviewing the merits and pitfalls of these applications. SUMMARY: From my analysis of the literature, I draw the following conclusions. ( a ) d-dimer, as measured by a sensitive test, can be safely used to exclude VTE in symptomatic outpatients, provided that it is used in combination with the pretest clinical probability. ( b ) High concentrations of d-dimer are associated with an increased risk of recurrent VTE. ( c ) Patients who present with d-dimer above cutoff after stopping the regular course of oral anticoagulation benefit from extended prophylaxis. ( d ) Finally, d-dimer can be used as a fibrin-related degradation marker for the diagnosis/management of patients with DIC.
No takes yet. Share an insight, caveat, or question.
Armando Tripodi (2012) conducted a review in Venous thromboembolism (VTE) and Disseminated intravascular coagulation (DIC). D-dimer testing was evaluated. D-dimer testing, when measured by a sensitive assay and combined with pretest clinical probability, can safely exclude venous thromboembolism in symptomatic outpatients.
Synapse has enriched 10 related papers. Consider them for comparative context: